TrialPanorama/TrialPanorama-database huggingface dataset:
Primary endpoint: Level of cooperation
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: visual field
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Efficacy of oral methotrexate treatment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global platform deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Lateral platform deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Global apex deviation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Apex depth deviations
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage of participants who completed scan
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Number of Participants With Abnormal ECG
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Percentage of study eyes with progressive myopia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with laboratory test findings of potential clinical importance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with vital signs findings of potential clinical importance
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Number of participants with ECG findings of potential clinical importance
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Correlation between inflammatory markers and CBC indices
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Retention of maxillary denture
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Hip, Knee and Spine Measurements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Intra-procedural lowest saturation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Need for multiple attempts
Endpoint domain: Adverse events/effects
Primary endpoint: Time taken for awake intubation
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Incidence of sepsis in CAP patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Weight trends
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Positive detection rate of CEA
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: incidence of procedure-related complications
Endpoint domain: Adverse events/effects
Primary endpoint: typical atrial flutter recurrence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Time required to perform the operative hysteroscopic procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Abbey Pain Hetero-Evaluation Scale
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in severity of pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: High-grade dysplasia or invasive cancer
Endpoint domain: Mortality/survival
Primary endpoint: Renal Function Indicators
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Successful discontinuation of Continuous Renal Replacement Therapy
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Clinical Judgment
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Abdominal Pain Responder Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Complete Spontaneous Bowel Movement (CSBM) Responder Rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Corneal-conjunctival staining
Endpoint domain: Physiological/clinical
Endpoint subdomain: Ocular outcomes
Primary endpoint: Percentage of patients reaching clinical remission at week 12
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Incidence of implant and/or procedure-related adverse events/complications
Endpoint domain: Adverse events/effects
Primary endpoint: Severin's grading
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in retinal sensitivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Prevalence of stature delay diagnoses in children
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Electroencephalogram (EEG)-Slow wave length
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Electroencephalogram (EEG)-Slow wave frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Hamilton Anxiety Rating Scale (HAMA)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Radial artery occlusion cut-off value
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Rate of diagnosis of cardiac amyloidosis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Total CD34+ cell yield
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Number of Participants Experiencing Hypoglycemia (BG<70 mg/dL)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of Participants Experiencing Clinically Significant Hypoglycemia (BG<54 mg/dL)
Endpoint domain: Adverse events/effects
Primary endpoint: Time in Range (TIR) Between 70-180 mg/dL
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Peak Knee Moment
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Four Square Step Test (4SST)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pharmacological measure of neuromuscular blocking drug effect
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Immunogenicity of 1-dose and 2-dose schedule
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Safety of one dose and two doses schedule
Endpoint domain: Adverse events/effects
Primary endpoint: Change in lower limb volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Curve to last measurable concentration
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Area Under the Concentration Curve from 0 to infinity
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: 0-2 h urine 13C Mannitol excretion
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Occurance of Dose-limiting toxicities
Endpoint domain: Adverse events/effects
Primary endpoint: Quality of life measured by DLQI questionnaire
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Plasma Metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Stool Metabolome
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: change of dermal thickness
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: visual-Attention Bias Index (vABI)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Peripheral lymphatic velocity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Peripheral lymphatic frequency
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Total New Lesion Volume
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Presence of ventricular remodelling
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Presence of ventricular arrythmia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Rate of dengue with warning signs
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: Preoperative pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Pain following regional anesthesia
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Errors during PPE assembly/preparation, donning and doffing
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Communication impairments while using PPE
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Perception regarding safety and satisfaction of the PPE user
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change from Baseline in fasting plasma glucose [FPG] at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in fasting plasma glucose [FPG] at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in glycated hemoglobin [HbA1c] at 12 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Change from Baseline in glycated hemoglobin [HbA1c] at 24 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Detection of novel biomarkers in ccRCC patients before surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of novel biomarkers in ccRCC patients 1 week after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Detection of novel biomarkers in ccRCC patients at 6 months after surgery
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acute Kidney Injury (AKI) Incidence
Endpoint domain: Physiological/clinical
Endpoint subdomain: Renal and urinary outcomes
Primary endpoint: Blood Transfusion Requirements
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Adverse events within 2 weeks of injection
Endpoint domain: Adverse events/effects
Primary endpoint: Perceived success of respiratory support
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Canadian Occupational Performance Measure - performance
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Change in Canadian Occupational Performance Measure - satisfaction
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Change in Performance Quality Rating Scale - occupational performance quality
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Change from baseline Sexual Dysfunction
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Time to maximal plasma concentration (Tmax)
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in QT and QTc intervals
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Change in abdominal wall pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Composite score of handgrip strength, muscle strength leg, muscle strength arm and exercise capacity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Musculoskeletal and connective tissue outcomes
Primary endpoint: Altered sensation in lip and/or chin
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Number of patients with sulfonylureas, mealtime, or mixed insulin discontinued
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Concentration of the elucidation in disease etiology
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of the elucidation in disease translation
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Concentration of the elucidation in advancing public health
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Role Clarity
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Task Mastery
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Social acceptance
Endpoint domain: Life impact
Endpoint subdomain: Social functioning
Primary endpoint: Very good partial response (VGPR) rate
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Acceptability and adherence to intervention
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Whole Body Fitness
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Skin appearance improvement
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes
Primary endpoint: elementary analysis of dentin
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of patients needing escalation of treatment
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Incidence of MCI converted to Alzheimer's disease
Endpoint domain: Mortality/survival
Primary endpoint: Global cognitive function of MCI patients
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Selection ratio of fertility preservation procedure
Endpoint domain: Physiological/clinical
Endpoint subdomain: Reproductive system and breast outcomes
Primary endpoint: Gain in developmental quotient
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Severity of Adverse Events related to treatment
Endpoint domain: Adverse events/effects
Primary endpoint: Correlation of Ga68-FAPI PET/CT derived PCI score with intraoperative PCI
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Polycystic Ovary Syndrome Health-Related Quality of Life Questionnaire (PCOSQ) score
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Lymphopenia
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: General Symptom Questionnaire-30
Endpoint domain: Life impact
Endpoint subdomain: Global quality of life
Primary endpoint: Quality of Life Experience Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: stride characteristics
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Walking oxygen uptake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total incidence of post-operative nausea
Endpoint domain: Adverse events/effects
Primary endpoint: Percentage of inpatients receiving addiction consult
Endpoint domain: Resource use
Endpoint subdomain: Need for further intervention
Primary endpoint: Difficulty of attempts
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: diaphragmatic paralysis
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Proportion of PLwO / participants who made serious weight loss effort
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Significant Hypoglycemia
Endpoint domain: Adverse events/effects
Primary endpoint: Severe hypoglycemia (needing assistance)
Endpoint domain: Adverse events/effects
Primary endpoint: Procrastination behaviour
Endpoint domain: Life impact
Endpoint subdomain: Cognitive functioning
Primary endpoint: Time management skills
Endpoint domain: Life impact
Endpoint subdomain: Role functioning
Primary endpoint: Attitude towards internet-based interventions
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Number of participants with serious treatment-emergent adverse events (TEAEs)
Endpoint domain: Adverse events/effects
Primary endpoint: Number of participants with infusion associated reactions (IARs)
Endpoint domain: Adverse events/effects
Primary endpoint: Urinary Catheter Self-Care Management Scale
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Grade of vein severity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Change in patient's assessment of global hand pain
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Change in Functional Index for Hand Osteoarthritis (FIHOA) score
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Left common iliac vein diameter
Endpoint domain: Physiological/clinical
Endpoint subdomain: Vascular outcomes
Primary endpoint: Diagnostic free survival time
Endpoint domain: Mortality/survival
Primary endpoint: Vaccine specific antibody titer
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Total Fecal Short Chain Fatty Acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Individual Fecal Short Chain Fatty Acids
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Type 2 diabetes risk score
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Number of fecal incontinence events
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Efficacy of 3D printed vascular stromal tissue and scaffolds
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Proportion of ambulant patients
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Ischemic Stroke Risk Prediction
Endpoint domain: Physiological/clinical
Endpoint subdomain: Cardiovascular outcomes
Primary endpoint: Malignancy excluding non-melanoma skin cancer (NMSC)
Endpoint domain: Mortality/survival
Primary endpoint: Venous thromboembolic events (VTE)
Endpoint domain: Adverse events/effects
Primary endpoint: Constipation scoring system
Endpoint domain: Physiological/clinical
Endpoint subdomain: Gastrointestinal outcomes
Primary endpoint: Interleukin 6 (IL-6) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Immune system outcomes
Primary endpoint: Adrenocorticotropic hormone (ACTH) level
Endpoint domain: Physiological/clinical
Endpoint subdomain: Endocrine outcomes
Primary endpoint: Total oxidative status (TOS) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Total antioxidative status (TAS) Level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Changes in objectively-measured sleep outcomes
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in subjectively-reported sleep quality
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Changes in perceived impairment during wake associated with sleep problems
Endpoint domain: Life impact
Endpoint subdomain: Fatigue
Primary endpoint: Death from any cause at hospital discharge
Endpoint domain: Mortality/survival
Primary endpoint: Severity of Parkinson's disease symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in peri-implant mucosal level
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: changes in gingival phenotype
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Average 89Zr-trastuzumab SUVmax of lesions
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Rate of endogenous glucose production
Endpoint domain: Physiological/clinical
Endpoint subdomain: Metabolic and nutritional outcomes
Primary endpoint: Rate of incomplete hematoma resolution
Endpoint domain: Physiological/clinical
Endpoint subdomain: Blood and lymphatic system outcomes
Primary endpoint: Rate of surgical rescue
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: RAO incidence during hospitalization
Endpoint domain: Adverse events/effects
Primary endpoint: Number of migraine days at week 1
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Percentage consumption of supplement gels
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Assessment of palatability of supplement gels
Endpoint domain: Life impact
Endpoint subdomain: Perceived health status
Primary endpoint: Measurement of dietary intake
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: Perfusion of the remaining lung lobe
Endpoint domain: Physiological/clinical
Endpoint subdomain: Respiratory outcomes
Primary endpoint: Strongyloides seropositivity
Endpoint domain: Physiological/clinical
Endpoint subdomain: Infections and infestations outcomes
Primary endpoint: extent of pain
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Percentage of participants achieving complete remission (CR)
Endpoint domain: Physiological/clinical
Endpoint subdomain: Neoplasms and related outcomes
Primary endpoint: Survival without moderate to severe bronchopulmonary dysplasia (BPD)
Endpoint domain: Mortality/survival
Primary endpoint: Actigraphically-Derived Total Sleep Time
Endpoint domain: Life impact
Endpoint subdomain: Sleep
Primary endpoint: Presence and Severity of CNS and PASC Symptoms
Endpoint domain: Physiological/clinical
Endpoint subdomain: General outcomes
Primary endpoint: The World Health Organisation - Five Well-Being Index (WHO-5)
Endpoint domain: Life impact
Endpoint subdomain: Emotional functioning/wellbeing
Primary endpoint: Change in physical component summary (PCS) of SF-12v2
Endpoint domain: Life impact
Endpoint subdomain: Physical functioning
Primary endpoint: Combined healing rate at 6 months
Endpoint domain: Physiological/clinical
Endpoint subdomain: Surgical and medical procedures outcomes
Primary endpoint: Neuro-sacral dysfunction assessment
Endpoint domain: Physiological/clinical
Endpoint subdomain: Nervous system outcomes
Primary endpoint: Transepidermal Water Loss
Endpoint domain: Physiological/clinical
Endpoint subdomain: Skin and subcutaneous tissue outcomes